Subcutaneous rituximab: a practical approach? - ScienceDirect

The Lancet Oncology

Volume 15, Issue 3, March 2014, Pages 254-255

The Lancet Oncology

https://doi.org/10.1016/S1470-2045(14)70009-9 Get rights and content

References (7)

C Müller et al.
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL
Blood
(2012)
J Atmar
Review of the safety and feasibility of rapid infusion of rituximab
J Oncol Pract
(2010)
GI Frost
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
Expert Opin Drug Deliv
(2007)

There are more references available in the full text version of this article.

Cited by (2)

Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A time and motion study in eight countries
2016, PLoS ONE
Special section on DMPK of therapeutic proteins - Minireview: Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins
2014, Drug Metabolism and Disposition

Copyright © 2014 Elsevier Ltd. All rights reserved.